Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/02/2024 ,inter alia, to consider and approve 1. To consider and approve the proposal for issuance of fully paid up bonus equity shares to the members of the Company subject to necessary approval; 2. To consider and approve the proposal of increase in the authorized share capital of the Company and subsequent alteration to the Memorandum of Association of the Company. if needed, subject to necessary approval; 3. To consider and finalize the matters to be included in Notice of EGM/Postal Ballot including day, Date, Place & Time, if required; Further, in terms of the SEBI (Prohibition of Insider Trading) Reg., 2015 and in accordance with the Company's Code of Conduct for Prevention of Insider Trading, the 'Trading Window' for dealing in securities of the Company shall remain closed from 23rd February, 2024 to 02nd March, 2024 (both days inclusive) i.e. till 48 hours after the public announcement of outcome of Board meeting scheduled to be held on February 29, 2024, for the designated employees of the Company.